IR
Superintel
Overview
Markets
Watchlist
More
Crispr Therapeutics AG
Q2 2021 vs Q3 2021
Comparing institutional holders between quarters
Quarters
Q3 2021
Q2 2021
Q1 2021
Q4 2020
Q3 2020
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
1
Filed
0
New
0
Closed
0
Increased
1
Decreased
0
Unchanged
0
No Data
Sort by
Q3 2021 shares — high to low
Q3 2021 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q3 2021 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Fairfield, Bush & Co.
DECREASED
Shares
7,000
from 7,150
Change
-150
(-2%)
Value
$784
(-$374)
Filed 2021-11-08
Institution
Status
Q3 2021 ↓
Q2 2021
Change
% Change
Q2 2021 Value
Q3 2021 Value
Value Change
Filed
Fairfield, Bush & Co.
DECREASED
7,000
7,150
-150
-2%
$1.2K
$784
-$374
2021-11-08
Showing 1 of 1 institutions